Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -24677.94% is 34276% below its 3-year average of -71.79%, near the low end of its 3-year range (-24677.94%–666984.16%).
1546.24% below its 12-month average of 1706.35%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
-24677.94%
GROSS MARGIN AVG TTM
1706.35%
GROSS MARGIN AVG 3Y
-71.79%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1546.24%
CURRENT VS 3Y AVG
-34275.95%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-59737.36%
vs the sector median at left
InflaRx N.V.
Market Cap
$233.46M
Gross Margin
-24677.94%
TTM Avg
1706.35%
3Y Avg
-71.79%
5Y Avg
0.00%
Market Cap
$234.54M
Gross Margin
68.57%
TTM Avg
73.00%
3Y Avg
80.96%
5Y Avg
81.80%
Market Cap
$235.04M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$235.73M
Gross Margin
54.88%
TTM Avg
55.31%
3Y Avg
58.01%
5Y Avg
59.27%
Market Cap
$236.39M
Gross Margin
79.48%
TTM Avg
71.93%
3Y Avg
74.52%
5Y Avg
72.98%
Market Cap
$230.79M
Gross Margin
99.39%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
25.00%
Market Cap
$236.58M
Gross Margin
53.14%
TTM Avg
76.57%
3Y Avg
72.53%
5Y Avg
61.83%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $233.46M | -24677.94% | 1706.35% | -71.79% | 0.00% |
| SIGA Technologies, Inc. (SIGA)vs › | $234.54M | 68.57% | 73.00% | 80.96% | 81.80% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $235.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.73M | 54.88% | 55.31% | 58.01% | 59.27% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.39M | 79.48% | 71.93% | 74.52% | 72.98% |
| BioAge Labs Inc. (BIOA)vs › | $230.79M | 99.39% | 50.00% | 25.00% | 25.00% |
| Invivyd, Inc. (IVVD)vs › | $237.22M | 91.35% | 93.31% | 46.66% | 31.10% |
| High Tide Inc. (HITI)vs › | $237.69M | 25.85% | 26.57% | 27.09% | 30.11% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $236.58M | 53.14% | 76.57% | 72.53% | 61.83% |
| MacroGenics, Inc. (MGNX)vs › | $228.83M | 71.12% | 81.41% | 85.88% | 90.00% |
Gross Margin
-24677.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 14418.50% |
| 2025-09-30 | 98.60% |
| 2025-06-30 | -5985.37% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 666984.16% |
| 2024-09-30 | 158.60% |
| 2024-06-30 | -5376.69% |
| 2024-03-31 | -511.93% |
| 2023-12-31 | -12023.62% |
| 2023-09-30 | -319.58% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
